These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15717181)

  • 1. Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Nakayasu K; Nagayama Y
    Eur J Pediatr; 2005 Mar; 164(3):186-7. PubMed ID: 15717181
    [No Abstract]   [Full Text] [Related]  

  • 2. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubulo-interstitial nephritis caused by sodium valproate.
    Yoshikawa H; Watanabe T; Abe T
    Brain Dev; 2002 Mar; 24(2):102-5. PubMed ID: 11891102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium valproate-induced Fanconi type proximal renal tubular acidosis.
    Knights M; Thekkekkara T; Morris A; Finlay E
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three cases of Fanconi syndrome associated with valproate sodium treatment].
    Inoue T; Tanaka Y; Otani R; Itabashi H; Murakami N; Nagai T; Sakuta R
    No To Hattatsu; 2011 May; 43(3):233-7. PubMed ID: 21638910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Biopsy Findings in a Patient With Valproic Acid-Associated Fanconi Syndrome.
    Singer P; Sethna CB; Castellanos-Reyes L; Yaskiv O; Bijol V
    Pediatr Dev Pathol; 2019; 22(4):370-374. PubMed ID: 30565480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible Fanconi syndrome associated with valproate therapy.
    Lande MB; Kim MS; Bartlett C; Guay-Woodford LM
    J Pediatr; 1993 Aug; 123(2):320-2. PubMed ID: 7688423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 17. [A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy].
    Ono H
    No To Hattatsu; 2007 May; 39(3):226-7. PubMed ID: 17515139
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of fetal valproate syndrome with new features expanding the phenotype.
    Al-Mendalawi MD; Seidahmed MZ
    Saudi Med J; 2009 Jul; 30(7):977; author reply 977-8. PubMed ID: 19618023
    [No Abstract]   [Full Text] [Related]  

  • 19. Fractures and Fanconi syndrome due to prolonged sodium valproate use.
    Dhillon N; Högler W
    Neuropediatrics; 2011 Jun; 42(3):119-21. PubMed ID: 21717384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs.
    Yüksel A; Cengiz M; Seven M; Cengiz S; Cenani A
    Pediatr Neurol; 1999 Jan; 20(1):24-6. PubMed ID: 10029255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.